Survival time after AIDS in pregnancy

Area of Science:

• Medical research
• Immunology
• Epidemiology

Background:

• Theoretical considerations and case reports suggested pregnancy might decrease survival time in women with acquired immunodeficiency syndrome (AIDS).
• Human immunodeficiency virus (HIV) infection prevalence in women necessitates understanding its impact on pregnancy outcomes.

Purpose of the Study:

• To investigate the association between pregnancy and survival time in women diagnosed with AIDS.
• To evaluate clinical characteristics, disease presentation, and laboratory markers in pregnant versus non-pregnant women with AIDS.

Main Methods:

• A total population study conducted in Edinburgh, a city with a moderately high prevalence of HIV infection in women.
• Analysis of 22 women diagnosed with AIDS, including five who were pregnant.
• Assessment of clinical findings, lymphocyte markers, pregnancy outcome, disease progression, and survival time.

Main Results:

• No obvious differences in clinical findings or laboratory markers were observed between pregnant and non-pregnant women with AIDS.
• The mean survival time for three deceased pregnant women was 24 months, compared to 15 months for 11 deceased non-pregnant women (P = 0.63).
• All three women who experienced Pneumocystis carinii pneumonia during pregnancy survived the initial episode.

Conclusions:

• Pregnancy does not appear to significantly alter the clinical presentation, illness severity, or laboratory findings in women with AIDS.
• Survival time was not demonstrably reduced by the co-occurrence of pregnancy and AIDS.
• The findings challenge previous suggestions that pregnancy negatively impacts AIDS prognosis.